| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |